Prudential Financial Inc. Cuts Stock Holdings in Molina Healthcare, Inc. (NYSE:MOH)

Prudential Financial Inc. reduced its position in shares of Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 14.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 29,807 shares of the company's stock after selling 5,209 shares during the period. Prudential Financial Inc. owned 0.05% of Molina Healthcare worth $8,675,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in MOH. True Wealth Design LLC lifted its position in shares of Molina Healthcare by 2,500.0% during the 3rd quarter. True Wealth Design LLC now owns 104 shares of the company's stock worth $36,000 after buying an additional 100 shares in the last quarter. Versant Capital Management Inc lifted its holdings in Molina Healthcare by 83.1% during the fourth quarter. Versant Capital Management Inc now owns 163 shares of the company's stock worth $47,000 after acquiring an additional 74 shares during the period. Wingate Wealth Advisors Inc. bought a new stake in Molina Healthcare during the fourth quarter worth $52,000. EverSource Wealth Advisors LLC boosted its position in Molina Healthcare by 81.5% in the fourth quarter. EverSource Wealth Advisors LLC now owns 196 shares of the company's stock worth $57,000 after purchasing an additional 88 shares during the last quarter. Finally, Whittier Trust Co. of Nevada Inc. grew its stake in Molina Healthcare by 337.0% in the 4th quarter. Whittier Trust Co. of Nevada Inc. now owns 201 shares of the company's stock valued at $58,000 after purchasing an additional 155 shares during the period. 98.50% of the stock is owned by institutional investors.

Remove Ads

Insider Buying and Selling

In other Molina Healthcare news, Director Steven J. Orlando sold 1,000 shares of the business's stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $301.33, for a total value of $301,330.00. Following the completion of the transaction, the director now owns 17,375 shares of the company's stock, valued at $5,235,608.75. The trade was a 5.44 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.10% of the stock is owned by company insiders.

Molina Healthcare Price Performance

MOH traded up $24.99 during trading on Thursday, reaching $353.48. 1,509,425 shares of the company were exchanged, compared to its average volume of 638,901. Molina Healthcare, Inc. has a 12-month low of $262.32 and a 12-month high of $383.58. The company's 50-day moving average is $305.90 and its two-hundred day moving average is $308.82. The company has a quick ratio of 1.62, a current ratio of 1.62 and a debt-to-equity ratio of 0.69. The company has a market cap of $19.34 billion, a price-to-earnings ratio of 17.30, a P/E/G ratio of 1.06 and a beta of 0.56.

Molina Healthcare (NYSE:MOH - Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $5.05 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $5.74 by ($0.69). Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. Research analysts forecast that Molina Healthcare, Inc. will post 24.4 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

MOH has been the topic of a number of recent analyst reports. StockNews.com cut Molina Healthcare from a "buy" rating to a "hold" rating in a research note on Thursday. Truist Financial lowered their price objective on shares of Molina Healthcare from $370.00 to $340.00 and set a "buy" rating on the stock in a research report on Wednesday, February 19th. Stephens reissued an "equal weight" rating and set a $345.00 target price on shares of Molina Healthcare in a research report on Thursday, February 6th. JPMorgan Chase & Co. restated a "neutral" rating and set a $350.00 price target (down previously from $378.00) on shares of Molina Healthcare in a research note on Tuesday, December 17th. Finally, Wells Fargo & Company upgraded Molina Healthcare from an "equal weight" rating to an "overweight" rating and upped their price objective for the company from $295.00 to $372.00 in a research note on Wednesday, March 5th. Seven equities research analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $348.75.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.